Home HealthTopics Health Centers Reference Library Research
Join us on Facebook Join us on Facebook Share on Facebook

Myasthenia Gravis

Cellcept

10/17/2008

Question:

What can you tell me about the effectiveness of Cellcept in treating MG?

Answer:

This year two studies came out in the literature that drew serious doubts for mycophenolate (Cellcept) as a first line agent for myasthenia. Cellcept was used in conjunction with prednisone and neither study showed any benefit for controlling myasthenia over prednisone alone. You will find many neurologists who do not use the drug now at all in myasthenia. But the debate still continues about this drug. One study was only 12 weeks; was this too short a time period to really determine if the drug was effective? Patients with severe myasthenia were excluded. Did we study enough patients? Anecdotally, I would say I have used it on several patients in the past, and had success in just a few of those treated. The drug seems to be much better tolerated than some of the other immunosuppressants and is also touted as having a lower risk of long-term hematologic malignancies. I still use it, but not as a first or second line agent. I have attached the two citations for your interest.

For more information:

Go to the Myasthenia Gravis health topic, where you can:

Response by:

Robert W Neel, IV, MD Robert W Neel, IV, MD
Assistant Professor of Neurology
College of Medicine
University of Cincinnati